Navigation Links
New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen
Date:11/13/2007

livery of the entire aspirin into the blood stream."

Some studies have shown that enteric-coated aspirin delivers just 50 percent of the dosage before the remaining tablet is eliminated by the body.

The quick-dissolve absorption also makes Fasprin the delivery of choice at the onset of a heart attack or stroke, where doctors recommend immediately administering aspirin. By doing so, aspirin can reduce the risk of death by as much as 23 percent, according to published studies.

Fasprin comes in a 30-tablet package (a month's supply), and carries a suggested retail price of $5.99. Fasprin is available wherever aspirin is sold, including Walgreens, CVS, Rite Aid, Albertsons, Meijer and Wal-Mart. The product is also available through the company's website at http://www.Fasprin.com.

[Product photos and additional stories available at http://www.improvita.com/fasprin-news.]

Contact:

Steve Corcoran

Vice President

Hybrid Marketing

Phone: 216-774-9274

Cell: 440-655-6073

corc@hybridmar.com

Tom Klamet

President

Improvita Health Products, Inc.

Phone: (216) 573-1850

tklamet@improvita.com


'/>"/>
SOURCE Improvita Health Products, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. New study: Pine bark reduces perimenopausal symptoms
2. Different method of evaluating the urinary tract system reduces radiation dose
3. Saline Reduces Mortality for Brain Injury Patients
4. New study: Pine bark extract reduces ADHD symptoms in children
5. Radiation therapy technique reduces length of prostate cancer treatment
6. Radiation therapy technique reduces length of prostate cancer treatment
7. MR spectroscopy identifies breast cancer, reduces biopsies
8. Body-mind meditation boosts performance, reduces stress
9. Parkinsons Institute research shows that nicotine reduces levodopa-induced dyskinesias
10. VIDEO from Medialink and EcoQuest: New Technology Reduces Exposure to MRSA Staph
11. Ranexa(R) Significantly Reduces Incidence of CV Death, MI or Recurrent Ischemia in MERLIN TIMI-36 Patients With Elevated BNP
Post Your Comments:
*Name:
*Comment:
*Email: